Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)
- 1 January 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 106 (1), 81-89
- https://doi.org/10.1111/j.1365-2133.1982.tb00905.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Detection of immune complexes in systemic sclerosis and Raynaud's phenomenonBritish Journal of Dermatology, 1981
- Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.Annals Of The Rheumatic Diseases, 1981
- PROSTACYCLIN INCREASES CYCLIC-NUCLEOTIDE RESPONSIVENESS OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC SCLEROSISThe Lancet, 1980
- Effects of intravenous infusion of prostacyclin (PGI2) in manProstaglandins, 1980
- Antibodies eluted from lymphoid cell membrane. Occurrence in certain varieties of sclerodermaArchives of Dermatology, 1979
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- Detection of circulating immune comlexes in some skin diseases by platelet aggregation testBritish Journal of Dermatology, 1979
- FEMORAL-ARTERY INFUSION OF PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1973
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- THE RADIATION OF HEAT FROM THE HUMAN BODYJCI Insight, 1934